Leerink Partners initiated coverage on Alamar Biosciences with a new price target
Stocks in this Quantisnow insightIndustrials
Historical context for ALMR
Across the 5 sessions after earlier ALMR headlines, the stock closed higher 2 times and lower 2 times, with a median move of 1.3% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | ALMR | SPY |
|---|---|---|---|
| May 12, 2026 | TD Cowen initiated coverage on Alamar Biosciences with a new price targetand 1 other headline that session | -3.8% | -0.2% |
| May 8, 2026 | Alamar Biosciences Reports First Quarter 2026 Financial Results | +1.3% | +0.8% |
| May 6, 2026 | Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference | -0.3% | +1.4% |
| May 1, 2026 | Alamar Biosciences to Report First Quarter 2026 Financial Results on May 8, 2026 | +3.1% | +0.3% |
| Apr 20, 2026 | Precision Proteomics Leader Alamar Biosciences Lists on NASDAQ | +0.0% | -0.2% |
Quantisnow market dataNASDAQ
ALMR
Alamar Biosciences Inc.
- Market cap
- 30-day
- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Listed since
- 2026
Get push alerts for ALMR
Full ALMR profile on Quantisnow Follow ALMR and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time